• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    More On RHHBY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Roche Holding AG (RHHBY)

    -Other OTC
    36.11 Up 0.06(0.17%) Jul 31, 4:00PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    ProfileGet Profile for:
    Roche Holding AG
    Konzern-Hauptsitz
    Grenzacherstrasse 124
    Basel, 4070
    Switzerland - Map
    Phone: 41 61 688 11 11
    Fax: 41 61 691 93 91
    Website: http://www.roche.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:88,509

    Business Summary 

    Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Europe, North America, and Asia. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, human papillomavirus, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases. The company also provides diagnostic solutions for blood gas analysis; blood screening; cancer screening; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring, routing, and specialty testing; data management; diabetes monitoring and therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogenous immune assays; immunology; infectious diseases; intensive care testing; microarray; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; pharmacogenomics; physical fitness and platelet function testing; PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. In addition, it offers products for researchers, such as amplification, cell analysis, gene expression, gene knockdown, genome sequencing, microarrays, nucleic acid purification, protein analysis, PCR systems, and transfection products. The company has collaboration agreements with AmorChem, AbbVie, Xenon Pharmaceuticals, Stratos Genomics, The Garvan Institute, Cornell University, and University of Washington. The company was founded in 1896 and is headquartered in Basel, Switzerland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Roche Holding AG

    Key Executives 
     PayExercised
    Dr. Severin Schwan Ph.D., 48
    Chief Exec. Officer and Director
    6.14MN/A
    Dr. Alan Hippe , 48
    Chief Financial Officer and IT Officer
    4.98MN/A
    Dr. Gottlieb A. Keller , 61
    Gen. Counsel and Corp. Sec.
    3.90MN/A
    Mr. Silvia Ayyoubi , 62
    Head of Group HR
    3.51MN/A
    Mr. Daniel O'Day , 51
    Chief Operating Officer of Pharmaceuticals division
    6.32MN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.